Europe Synthetic Biology Market to 2028 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Synthetic Biology Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Synthetic Biology Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Investments in Synthetic Biology owing to various start-ups offer solutions for difficult microbial systems

5.2 Market Opportunities

5.2.1 Collaboration between companies so they can collaborate inter-disciplinary globally between synthetic biologists, policymakers, researchers, and industry

5.3 Future Trends

5.3.1 Rising Number of Start-Ups

5.4 Impact of Drivers and Restraints

6. Europe Synthetic Biology Market Regional Analysis

6.1 Europe Synthetic Biology Market Overview

6.2 Europe Synthetic Biology Market Revenue 2019-2028 (US$ Million)

6.3 Europe Synthetic Biology Market Forecast Analysis

7. Europe Synthetic Biology Market Analysis – by Products

7.1 Enzymes

7.1.1 Overview
7.1.2 Enzymes: Europe Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Chassis Organisms

7.2.1 Overview
7.2.2 Chassis Organisms: Europe Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Oligonucleotides

7.3.1 Overview
7.3.2 Oligonucleotides: Europe Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Xeno-Nucleic Acids

7.4.1 Overview
7.4.2 Xeno-Nucleic Acids: Europe Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Synthetic Biology Market Analysis – by Technology

8.1 Measurement & Modeling

8.1.1 Overview
8.1.2 Measurement & Modeling: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Cloning & Sequencing

8.2.1 Overview
8.2.2 Cloning & Sequencing: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Genome Engineering

8.3.1 Overview
8.3.2 Genome Engineering: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Gene Synthesis

8.4.1 Overview
8.4.2 Gene Synthesis: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Nanotechnology

8.5.1 Overview
8.5.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Synthetic Biology Market Analysis – by Application

9.1 Medical Applications

9.1.1 Overview
9.1.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Industrial Applications

9.2.1 Overview
9.2.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Food and Agriculture

9.3.1 Overview
9.3.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Environmental Applications

9.4.1 Overview
9.4.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Synthetic Biology Market – Europe Analysis

10.1 Europe

10.1.1 Europe Synthetic Biology Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Synthetic Biology Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Synthetic Biology Market Breakdown, by Products
10.1.1.1.2 UK: Europe Synthetic Biology Market Breakdown, by Technology
10.1.1.1.3 UK: Europe Synthetic Biology Market Breakdown, by Application

10.1.1.2 Germany: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Synthetic Biology Market Breakdown, by Products
10.1.1.2.2 Germany: Europe Synthetic Biology Market Breakdown, by Technology
10.1.1.2.3 Germany: Europe Synthetic Biology Market Breakdown, by Application

10.1.1.3 France: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Synthetic Biology Market Breakdown, by Products
10.1.1.3.2 France: Europe Synthetic Biology Market Breakdown, by Technology
10.1.1.3.3 France: Europe Synthetic Biology Market Breakdown, by Application

10.1.1.4 Russia: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Synthetic Biology Market Breakdown, by Products
10.1.1.4.2 Russia: Europe Synthetic Biology Market Breakdown, by Technology
10.1.1.4.3 Russia: Europe Synthetic Biology Market Breakdown, by Application

10.1.1.5 Italy: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Synthetic Biology Market Breakdown, by Products
10.1.1.5.2 Italy: Europe Synthetic Biology Market Breakdown, by Technology
10.1.1.5.3 Italy: Europe Synthetic Biology Market Breakdown, by Application

10.1.1.6 Rest of Europe: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Products
10.1.1.6.2 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Technology
10.1.1.6.3 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Synthetic Biology Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Amyris

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Codexis

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Genscript Biotech corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Integrated DNA Technologies

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 New England Biolabs

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Novozymes A/S

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Thermo Fisher Scientific

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Twist Bioscience

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights